Cargando…

Consensus statements on PSMA PET/CT response assessment criteria in prostate cancer

PURPOSE: Prostate-specific membrane antigen (PSMA) positron emission tomography (PET)/computed tomography (CT) is used for (re)staging prostate cancer (PCa) and as a biomarker for evaluating response to therapy, but lacks established response criteria. A panel of PCa experts in nuclear medicine, rad...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fanti, Stefano, Goffin, Karolien, Hadaschik, Boris A, Herrmann, Ken, Maurer, Tobias, MacLennan, Steven, Oprea-Lager, Daniela E., Oyen, Wim JG, Rouvière, Olivier, Mottet, Nicolas, Bjartell, Anders
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835167/ https://www.ncbi.nlm.nih.gov/pubmed/32617640 http://dx.doi.org/10.1007/s00259-020-04934-4

Ejemplares similares

Is PSMA PET/CT cost-effective for the primary staging in prostate cancer? First results for European countries and the USA based on the proPSMA trial
por: Holzgreve, Adrien, et al.
Publicado: (2023)

E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET
por: Ceci, Francesco, et al.
Publicado: (2021)

Enzalutamide Enhances PSMA Expression of PSMA-Low Prostate Cancer
por: Staniszewska, Magdalena, et al.
Publicado: (2021)

Consensus Procedures in Oncological Imaging: The Case of Prostate Cancer
por: Fanti, Stefano, et al.
Publicado: (2019)

PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0
por: Fendler, Wolfgang P., et al.
Publicado: (2023)

Pharmacological Optimization of PSMA-Based Radioligand Therapy
por: van der Gaag, Suzanne, et al.
Publicado: (2022)

It is time for consensus on ‘consensus statements’
por: Blazey, Paul, et al.
Publicado: (2022)

Consensus statement on standards and guidelines for the molecular diagnostics of Alport syndrome: refining the ACMG criteria
por: Savige, Judy, et al.
Publicado: (2021)

Repeatability of (68)Ga-PSMA-HBED-CC PET/CT–Derived Total Molecular Tumor Volume
por: Seifert, Robert, et al.
Publicado: (2022)

PSMA PET total tumor volume predicts outcome of patients with advanced prostate cancer receiving [(177)Lu]Lu-PSMA-617 radioligand therapy in a bicentric analysis
por: Seifert, Robert, et al.
Publicado: (2020)

Targeting PSMA Revolutionizes the Role of Nuclear Medicine in Diagnosis and Treatment of Prostate Cancer
por: Luining, Wietske I., et al.
Publicado: (2022)

Analysing the tumor transcriptome of prostate cancer to predict efficacy of Lu-PSMA therapy
por: Handke, Analena, et al.
Publicado: (2023)

Phase 3 multicenter randomized trial of PSMA PET/CT prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer [PSMA dRT]: study protocol
por: Calais, Jeremie, et al.
Publicado: (2021)

Committee Reports & Consensus Statements
Publicado: (2009)

CONSENSUS STATEMENT ON THE MANAGEMENT OF URTICARIA
por: Godse, Kiran V, et al.
Publicado: (2011)

Consensus statement on diabetes in children
por: Prasanna Kumar, K. M., et al.
Publicado: (2014)

Inhaled treatment of COPD: a Delphi consensus statement
por: Ninane, Vincent, et al.
Publicado: (2017)

Consensus statement from the International Consensus Meeting on the Role of Decompressive Craniectomy in the Management of Traumatic Brain Injury: Consensus statement
por: Hutchinson, Peter J., et al.
Publicado: (2019)

Consensus Report on Shigella Controlled Human Infection Model: Introduction and Overview
por: MacLennan, Calman A, et al.
Publicado: (2019)

The oncological characteristics of non‐prostate‐specific membrane antigen (PSMA)‐expressing primary prostate cancer on preoperative PSMA positron emission tomography/computed tomography
por: Veerman, Hans, et al.
Publicado: (2022)

Consensus Statements on the Assessment of Older Drivers
por: Hogan MD, David B., et al.
Publicado: (2014)

Parma consensus statement on metabolic disruptors
por: Heindel, Jerrold J., et al.
Publicado: (2015)

ACVIM consensus statement on pancreatitis in cats
por: Forman, Marnin A., et al.
Publicado: (2021)

The 2020 NBA Orthobiologics Consensus Statement
por: Cole, Brian J., et al.
Publicado: (2021)

Investigation of the halo-artifact in (68)Ga-PSMA-11-PET/MRI
por: Heußer, Thorsten, et al.
Publicado: (2017)

Consensus statement from the international consensus meeting on post-traumatic cranioplasty
por: Iaccarino, C., et al.
Publicado: (2020)

Contributions of multimodal imaging
por: Oyen, Wim JG
Publicado: (2014)

Proinsulin C-peptide - A Consensus Statement
por: Sima, Anders A. F., et al.
Publicado: (2001)

Consensus Statement on Mandatory Registration of Clinical Trials
Publicado: (2007)

Consensus conference on platelet transfusion: final statement.
Publicado: (1998)

A healthy bladder: a consensus statement
por: Lukacz, E S, et al.
Publicado: (2011)

The Malaysian consensus statement on utilisation of cardiac CT
por: Sim, KH, et al.
Publicado: (2008)

The second ESGAR consensus statement on CT colonography
por: Neri, Emanuele, et al.
Publicado: (2012)

AOSSM Early Sport Specialization Consensus Statement
por: LaPrade, Robert F., et al.
Publicado: (2016)

II Brazilian consensus statement on endoscopic ultrasonography
por: Maluf-Filho, Fauze, et al.
Publicado: (2017)

Correction to: Parma consensus statement on metabolic disruptors
por: Heindel, Jerrold J., et al.
Publicado: (2017)

Homocysteine and Dementia: An International Consensus Statement(1)
por: Smith, A. David, et al.
Publicado: (2018)

Do not do in COPD: consensus statement on overuse
por: Villar-Álvarez, Felipe, et al.
Publicado: (2018)

ECEIM consensus statement on equine metabolic syndrome
por: Durham, Andy E., et al.
Publicado: (2019)

BRAZILIAN CONSENSUS STATEMENT ON VISCOSUPPLEMENTATION OF THE KNEE (COBRAVI)
por: de Campos, Gustavo Constantino, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vf5aqhj7k3uokua75sttpetd6h